Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Galectin Therapeutics Q1 EPS $(0.17) Down From $(0.11) YoY

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.17) per share. This is a 54.55 percent decrease over losses of $(0.11) per share from the same period last year.
byBenzinga Newsdesk
May 16, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.17) per share. This is a 54.55 percent decrease over losses of $(0.11) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts